Enjoy complimentary customisation on priority with our Enterprise License!
The bipolar disorder therapeutics market size is forecast to increase by USD 787.02 million at a CAGR of 2.68% between 2023 and 2028. The market is experiencing significant growth due to the rising incidence of this mental health condition. According to the National Institute of Mental Health, approximately 2.8% of adults in the United States have bipolar disorder. The market is driven by the development of innovative treatments, including tricyclic antidepressant drugs, beta blockers, anti-psychotic drugs, lithium (Li) element, vasopressin hormone, and anticonvulsant drugs. These medications help manage the symptoms of bipolar disorder, which include extreme mood swings between mania and depression. Another trend in the market is the increasing prevalence of personalized treatment approaches due to advances in genetics and neuroscience. This personalization allows for more effective treatment plans tailored to individual patients, leading to better outcomes. However, the stigma surrounding mental health issues remains a challenge, hindering diagnosis and treatment. The market is expected to continue growing as research and development efforts continue to uncover new treatment options and improve existing ones.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Drug Class
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.